Our Team

Expertise that moves science forward

At Clarenta, our people are the driving force behind every successful study. As a European CRO specializing in early-phase clinical trials, we bring together deep scientific expertise, operational excellence and 29 years of industry experience.

Building on a proven track record of more than 950 completed clinical trials, our teams work as trusted partners to deliver flexible, tailored solutions that keep drug development programs moving forward – on time, within budget and to the highest standards of quality.

United by collaboration, integrity and a shared commitment to advancing medical innovation, we turn complex challenges into clear paths forward. Meet the people whose expertise, dedication and fresh thinking bring clarity to clinical development.

Executive Board
Chris Smyth
Chief Executive Officer
Peter Windisch
Chief Operations Officer
Steve Angus
Chief Financial Officer
Tanja Ouimet
Chief Business Officer & Executive Director
London, UK, September 9, 2026 – Comac Medical Group today announced its rebrand as Clarenta, introducing a new…
Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical…
Sofia, Bulgaria, April 28, 2025 – Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe,…